Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola disease, an early-onset recessive form of dementia preceded by bone cysts and fractures. The same type of mutations has recently been shown to cause frontotemporal dementia (FTD) without the presence of any bone phenotype. Here, we further confirm the association of TREM2 mutations with FTD-like phenotypes by reporting the first compound heterozygous mutation in a Turkish family.

Highlights

  • Nasu-Hakola disease (NHD, OMIM 221770), known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, is a rare autosomal recessive disease characterized by a combination of progressive young-onset dementia and multifocal bone cysts (Paloneva et al, 2001)

  • NHD is caused by mutations in 1 of 2 genes: TYRO protein tyrosine kinaseebinding protein (TYROBP) on chromosome 19q13.1 and triggering receptor expressed on myeloid cells 2 (TREM2) on chromosome 6p21.1

  • Cases with homozygous mutations in TREM2 have been described to present atypical phenotypes resembling behavioral variant frontotemporal dementia and lacking stage (2) of the clinical picture described previously (Chouery et al, 2008; Giraldo et al, 2013; Guerreiro et al, 2013b)

Read more

Summary

Introduction

Nasu-Hakola disease (NHD, OMIM 221770), known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, is a rare autosomal recessive disease characterized by a combination of progressive young-onset dementia and multifocal bone cysts (Paloneva et al, 2001). Cases with homozygous mutations in TREM2 have been described to present atypical phenotypes resembling behavioral variant frontotemporal dementia (bvFTD) and lacking stage (2) of the clinical picture described previously (Chouery et al, 2008; Giraldo et al, 2013; Guerreiro et al, 2013b). 14 different mutations have been identified in TREM2 including nonsense, missense, small deletions, and splice site homozygous mutations (Giraldo et al, 2013). We report the first TREM2 compound heterozygous mutation identified in a Turkish family presenting with an FTD-like phenotype

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.